Herbert Eradat, MD, MS @dgsomucla Associate Clinical Professor UCLE Lymphoma Program UCLA BMT & CAR-T Cell Program, David Geffen School of Medicine UCLA discusses An Update on Diffuse Large B-Cell Lymphoma Novel Therapeutic Strategies at the MOASC Summit 2020
Sponsors:
AbbVie
AMAG
AstraZeneca
Bayer
BeiGene
Clovis Oncology
Coherus
Daiichi-Sankyo
Dova Pharmaceuticals
Foundation Medicine
Jazz Pharmaceuticals
Merck
Pfizer Oncology
Puma Biotechnology
Tempus
Verastem oncology
Walgreens
Advertisement